Giripladib structure
|
Common Name | Giripladib | ||
---|---|---|---|---|
CAS Number | 865200-20-0 | Molecular Weight | 745.25 | |
Density | 1.29g/cm3 | Boiling Point | N/A | |
Molecular Formula | C41H36ClF3N2O4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of GiripladibGiripladib (PLA-695) is a indole-based inhibitor of cytosolic phospholipase A2 (cPLA2). Giripladib can be used for osteoarthritis and breast cancer research[1][2]. |
Name | Giripladib |
---|---|
Synonym | More Synonyms |
Description | Giripladib (PLA-695) is a indole-based inhibitor of cytosolic phospholipase A2 (cPLA2). Giripladib can be used for osteoarthritis and breast cancer research[1][2]. |
---|---|
Related Catalog | |
Target |
cPLA2α |
References |
Density | 1.29g/cm3 |
---|---|
Molecular Formula | C41H36ClF3N2O4S |
Molecular Weight | 745.25 |
Exact Mass | 744.20400 |
PSA | 96.78000 |
LogP | 10.95850 |
Storage condition | -20°C |
PLA 695 |
4-[3-[1-benzhydryl-5-chloro-2-[2-[[2-(trifluoromethyl)phenyl]methylsulfonylamino]ethyl]indol-3-yl]propyl]benzoic acid |